Genomine, Inc. is a private biotechnology company founded in 1999, with its headquarters located in Pohang-si, South Korea. The company is primarily engaged in the development of cutting-edge solutions in the field of biotechnology. It focuses on areas such as biomarker detection and related medical technologies, as demonstrated by its portfolio of patents. Notably, Genomine has secured multiple patents related to innovative diagnostic tools, including those for detecting renal cancer biomarkers. The company has continued to make strides in biotechnology, showcasing active research and development efforts aimed at expanding its technological footprint. Dongsoo Kim currently serves as the CEO, overseeing the company’s operations as it advances in medical and biotechnological innovations